Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124451283 | 12445128 | 3 | F | 201401 | 20160701 | 20160607 | 20160705 | EXP | US-009507513-1606USA001420 | MERCK | 52.37 | YR | M | Y | 104.30000 | KG | 20160705 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124451283 | 12445128 | 1 | PS | COZAAR | LOSARTAN POTASSIUM | 1 | Oral | 50 MG, ONCE A DAY | 20386 | 50 | MG | TABLET | QD | ||||||
| 124451283 | 12445128 | 2 | SS | FUROSEMIDE. | FUROSEMIDE | 1 | Oral | 40 MG, TWICE A DAY | 0 | 40 | MG | TABLET | BID | ||||||
| 124451283 | 12445128 | 3 | SS | ASPIRIN. | ASPIRIN | 1 | Oral | 81 MG, ONCE A DAY | 0 | 81 | MG | TABLET | QD | ||||||
| 124451283 | 12445128 | 4 | SS | ROPINIROLE. | ROPINIROLE | 1 | Oral | UNK | 0 | TABLET | |||||||||
| 124451283 | 12445128 | 5 | SS | ROPINIROLE. | ROPINIROLE | 1 | Oral | 2 TABLETS IN THE MORNING AND 2 TABLETS AT NIGHT | 0 | 2 | DF | TABLET | BID | ||||||
| 124451283 | 12445128 | 6 | SS | LYRICA | PREGABALIN | 1 | Oral | 75 MG (1 CAPSULE) TWICE A DAY | 0 | 75 | MG | CAPSULE | BID | ||||||
| 124451283 | 12445128 | 7 | SS | LYRICA | PREGABALIN | 1 | Oral | 150 MG (2 CAPSULES) TWICE A DAY | 0 | 150 | MG | CAPSULE | BID | ||||||
| 124451283 | 12445128 | 8 | SS | LYRICA | PREGABALIN | 1 | Oral | 75 MG (1 CAPSULE) TWICE A DAY | M71818 | 0 | 75 | MG | CAPSULE | BID | |||||
| 124451283 | 12445128 | 9 | C | FAMOTIDINE. | FAMOTIDINE | 1 | Oral | 40 MG ONCE A DAY | U | 0 | 40 | MG | TABLET | QD | |||||
| 124451283 | 12445128 | 10 | C | ZANTAC | RANITIDINE HYDROCHLORIDE | 1 | Oral | 150 MG, TWICE A DAY | U | 0 | 150 | MG | BID | ||||||
| 124451283 | 12445128 | 11 | C | CARVEDILOL. | CARVEDILOL | 1 | Oral | 12.5 MG TABLETS TWICE A DAY | U | 0 | TABLET | BID | |||||||
| 124451283 | 12445128 | 12 | C | SPIRONOLACTONE. | SPIRONOLACTONE | 1 | Oral | 50 MG, BID | U | 0 | 50 | MG | BID | ||||||
| 124451283 | 12445128 | 13 | C | UBIDECARENONE | UBIDECARENONE | 1 | Oral | 100 MG ONCE A DAY | U | 0 | 100 | MG | QD | ||||||
| 124451283 | 12445128 | 14 | C | FENOFIBRATE. | FENOFIBRATE | 1 | Oral | 160 MG, QD | U | 0 | 160 | MG | TABLET | QD | |||||
| 124451283 | 12445128 | 15 | C | ATORVASTATIN | ATORVASTATIN | 1 | Oral | 40 MG ONCE A DAY | U | 0 | 40 | MG | TABLET | QD | |||||
| 124451283 | 12445128 | 16 | C | ACETAMINOPHEN AND CODEINE | ACETAMINOPHENCODEINE PHOSPHATE | 1 | Oral | 300-60 MG EVERY 4 HOURS 6 TIMES A DAY | U | 0 | Q4H |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124451283 | 12445128 | 1 | Blood pressure abnormal |
| 124451283 | 12445128 | 2 | Diuretic therapy |
| 124451283 | 12445128 | 3 | Anticoagulant therapy |
| 124451283 | 12445128 | 4 | Restless legs syndrome |
| 124451283 | 12445128 | 6 | Restless legs syndrome |
| 124451283 | 12445128 | 9 | Gastric disorder |
| 124451283 | 12445128 | 10 | Gastrooesophageal reflux disease |
| 124451283 | 12445128 | 11 | General physical condition abnormal |
| 124451283 | 12445128 | 12 | Diuretic therapy |
| 124451283 | 12445128 | 13 | Routine health maintenance |
| 124451283 | 12445128 | 14 | Blood triglycerides increased |
| 124451283 | 12445128 | 15 | Blood cholesterol increased |
| 124451283 | 12445128 | 16 | Pain |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124451283 | 12445128 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124451283 | 12445128 | Altered state of consciousness | |
| 124451283 | 12445128 | Dizziness | |
| 124451283 | 12445128 | Nausea | |
| 124451283 | 12445128 | Sleep apnoea syndrome | |
| 124451283 | 12445128 | Somnolence | |
| 124451283 | 12445128 | Spinal fusion surgery | |
| 124451283 | 12445128 | Vision blurred |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124451283 | 12445128 | 1 | 2013 | 0 | ||
| 124451283 | 12445128 | 2 | 201310 | 0 | ||
| 124451283 | 12445128 | 3 | 201310 | 0 | ||
| 124451283 | 12445128 | 5 | 20160412 | 0 | ||
| 124451283 | 12445128 | 6 | 2015 | 0 | ||
| 124451283 | 12445128 | 7 | 20160412 | 20160416 | 0 | |
| 124451283 | 12445128 | 8 | 20160417 | 0 | ||
| 124451283 | 12445128 | 11 | 201310 | 0 | ||
| 124451283 | 12445128 | 12 | 201310 | 0 | ||
| 124451283 | 12445128 | 13 | 201310 | 0 | ||
| 124451283 | 12445128 | 14 | 2014 | 0 | ||
| 124451283 | 12445128 | 15 | 2014 | 0 |